NCT00410358 2020-12-19
A Dose Escalation of Gimatecan Administered Orally to Japanese Patients With Advanced Solid Tumor.
Novartis
Phase 1 Completed
Clinical Trials
4 trialsNCT00441610 2020-12-19
An Extension Trial to a Phase I Dose Escalation Study of Gimatecan Administered Orally 5 Consecutive Days to Japanese Patients With Advanced Solid Tumor
Novartis
Phase 1 Completed
NCT00420485 2013-04-19
Dose-escalation Study of Gimatecan Administered in Two Different Schedules in Adult Patients With Advanced Solid Tumors
Novartis
Phase 1 Completed
NCT00487058 2009-11-19
A Phase I Dose Escalation Study of LBQ707 (Gimatecan) Administered Orally Twice Per Week to Japanese Patients With Advanced Solid Tumors
Novartis
Phase 1 Completed